“Toxicology studies were conducted with MLN0002 in two species (rabbit and Cynomolgus monkeys) by intravenous (IV) route to support the chronic use of MLN0002.”
✓ VerifiedFDA pharmacology/toxicology review, p. 11Source ↗
Why that species
Similar binding affinity to rabbit, monkey and human leukocytes; no binding to mouse, rat or guinea pig leukocytes
“MLN0002 bound with similar affinity to leukocytes from rabbits, monkeys, and humans, but not from mice, rats, or guinea pigs.”
✓ VerifiedFDA pharmacology/toxicology review, p. 129Source ↗
Surrogate molecule
No surrogate; the clinical antibody was tested in rabbits and cynomolgus monkeys
“Toxicology studies were conducted with MLN0002 in two species (rabbit and Cynomolgus monkeys) by intravenous (IV) route to support the chronic use of MLN0002.”
✓ VerifiedFDA pharmacology/toxicology review, p. 11Source ↗